SCHEMBL256560

SCHEMBL256560

O[C@@H](CCc1ccccc1)CNCc1cccc(CC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BCHE P06276 9/20 0.46
BACE1 P56817 5/20 0.46
LMNA P02545 1/20 0.41
CETP P11597 1/20 0.40
DNM1 Q05193 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18767066 0.84 BCHE (0.63) BCHEBACE1
SCHEMBL6694692 0.81 DNM1 (0.54) BCHELMNADNM1
SCHEMBL5219603 0.81 DNM1 (0.54) BCHELMNADNM1
SCHEMBL5392678 0.81 CETP (0.50) BCHEBACE1CETPDNM1
SCHEMBL257187 0.78 BACE1 (0.49) BCHEBACE1
SCHEMBL5216600 0.78 BACE1 (0.49) BCHEBACE1LMNA
SCHEMBL168266 0.76 DNM1 (0.62) BCHEDNM1
SCHEMBL5930107 0.73 SMN1; SMN2 (0.48) BCHELMNADNM1
SCHEMBL13333754 0.73 BACE1 (0.45) BCHEBACE1
SCHEMBL5930378 0.71 CYP1A2 (0.56) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed